| Application no. and date | 15837091.6 (espacenet) (Federated) (European Patent Register), 20151026 | | Patent/reg. no. and date | DK/EP 3212629, 20181024 | | Publication date | 20170906 | | Priority no. and date | US 201462073325 P, 20141031 | | EP pub. no. and date |
EP 3212629 20170906 | | Effective date | | | Applicant/owner | Genoscience Pharma SAS, 10, rue d'Iena
13006 Marseille, FR | | Applicant ref. no. | P065552DK | | Inventor | HALFON, Philippe, 6, Allée du Chateau
Parc Marveyre
13008 Marseille, FR,
BASSISSI, Firas, 19, rue Pierre Laurent
Appartement 104
13006 Marseille, FR,
BERET, Antoine, 54, Chemin de Morgiou
13009 Marseille, FR,
BRUN, Sonia, Résidence les Fleurs
Appartement B201
115, rue Isaac Newton
13100 Aix-en-Provence, FR,
DUBRAY, Clarisse, Le Belvédère
Appartement B305
17, rue du Docteur Alfred Corlay
44800 Saint-Herblain, FR,
NICOLAS, Gregory, 8, rue des Saules
35510 Cesson Sevigne, FR,
COURCAMBECK, Jérôme, 50, Boulevard du Vaisseau
Les Hauts de Mazargues D5
13009 Marseille, FR | | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | | Opponent | | | IPC Class | A61K 31/47 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | | Title | Substitueret 2,4 diamino-quinolin som nye anticancermidler | | Int. application no. | IB2015002438 | | Int. publication no. | WO2016067112 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
